Status:

COMPLETED

Efficacy of Notrande Shuhuajun Probiotic Supplement on Lmproving Constipation in Preschool Children

Lead Sponsor:

Shandong Sibote Biotechnology Co., Ltd.

Conditions:

Functional Constipation (FC)

Eligibility:

All Genders

3-6 years

Phase:

NA

Brief Summary

The goal of this interventional study is to evaluate the effectiveness of Notrande Shuhuajun Probiotic Supplement intake on the improvement of functional constipation in preschool children (3-6 years ...

Eligibility Criteria

Inclusion

  • Participants must be preschool children (aged 3-6);
  • Participants were diagnosed with functional constipation based on Rome IV criteria;
  • Participants agreed not to take any drugs, supplements, or other dairy products during the trial period;
  • Participants agreed not to take any other prebiotic/bacterial drugs, supplements, or dairy products including yogurt beverages during the trial period;
  • Be willing to refrain from participating in other interventional clinical studies during the trial period;
  • Be able to fully understand the nature, purpose, benefits obtained, as well as possible risks and side effects of this study;
  • Be willing to comply with all test requirements and procedures;
  • Sign the informed consent form;

Exclusion

  • In the treatment of gastrointestinal symptoms;
  • Lactose intolerance;
  • Currently suffering from other organic diseases that affect intestinal function, such as a history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc;
  • Have been controlling diet, increasing exercise, or taking drugs to control weight or affect appetite in the last three months;
  • Have any of the following medical histories or have been clinically diagnosed with any of the following diseases that may affect the evaluation of the trial effect: obvious gastrointestinal dysfunction, liver, kidney, endocrine, blood, respiratory and cardiovascular diseases;
  • Current or past abuse of alcohol or other prohibited drugs, supplements or OTC prescription drugs may cause intestinal dysfunction or affect the evaluation of the test results;
  • According to the researchers' judgment, drugs that may affect gastrointestinal function or the immune system are currently being frequently used;
  • Laxatives or other digestive AIDS were used two weeks before the start of the trial;
  • Have consumed dairy products or other foods containing prebiotics/bacteria 10 days before the start of the trial;
  • The research doctors believed that the volunteers could not fully cooperate with the trial arrangements;

Key Trial Info

Start Date :

May 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 24 2025

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT07002489

Start Date

May 30 2025

End Date

August 24 2025

Last Update

December 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fuyang Fifth People's Hospital Quanying Branch

Fuyang, Anhui, China